In 2017, this cross-institutional research project led by HKUST was selected as an Area of Excellence (AoE) scheme and awarded HK$63.578 million from the Research Grants Council of Hong Kong for an eight-year period consisting of two phases. This project aims to lay crucial groundwork for delineating the key molecular mechanisms involved in cognitive dysfunction in neurodegenerative diseases such as Alzheimer’s disease. Advancement of this initiative will greatly facilitate the development of new therapeutics that improve the lives of millions of affected patients worldwide, while highlighting Hong Kong’s excellent neuroscience research capacities and infrastructure.
Between 2017 and mid-2020, efforts focused upon the AoE scheme resulted in the publication of 37 scientific papers in high-impact journals, along with 64 invited talks at international conferences and academic institutions. By sharing expertise and insights as well as research technology and materials, team members have established collaborations both locally and internationally, successfully endeavoring novel developments and findings.
- Vice-President for Research and Development
- The Morningside Professor of Life Science
- Chair Professor, Division of Life Science
- Director of State Key Laboratory of Molecular Neuroscience
An international research team co-led by HKUST, Beijing Neurosurgical Institute, and the Spanish National Cancer Research Center (CNIO) has discovered a mechanism that...
Researchers from HKUST discovered a novel molecular mechanism that controls the delivery of a key protein in planar cell polarity (PCP)...